HomeTrialNCT05683379
🔬NCT05683379RECRUITING

AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD

Study Summary

This is an observational screening study to evaluate the prevalence of anti-adeno-associated serotype 8 (AAV8) antibodies in participants with Duchenne muscular dystrophy (DMD).

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment200 participants
Primary Completion
Lead SponsorREGENXBIO Inc.
Data Retrieved2026-04-11 04:25:55.708121+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.